Ginkgo Bioworks director Shetty sells $175k in shares
#Ginkgo Bioworks #insider trading #SEC filing #stock sale #synthetic biology
📌 Key Takeaways
- Ginkgo Bioworks director Reshma Shetty sold about $175,000 in company shares.
- The sale was executed on March 14, 2025, under a pre-arranged trading plan.
- The transaction was disclosed in a mandatory SEC Form 4 filing.
- Insider sales are monitored as potential indicators of executive confidence but may be for personal financial reasons.
📖 Full Retelling
🏷️ Themes
Corporate Governance, Biotechnology, Financial Markets
📚 Related People & Topics
SEC filing
Type of financial statements in the United States
# SEC Filing An **SEC filing** is a formal financial statement or regulatory document submitted to the **U.S. Securities and Exchange Commission (SEC)**. These filings are mandatory requirements designed to ensure transparency, providing a standardized method for disclosing material information to ...
Ginkgo Bioworks
American biotechnology company
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of repr...
Entity Intersection Graph
Connections for SEC filing: